Celgene Corp. to pay $280M to settle cancer drug fraud suit
Tuesday, July 25, 2017 - 16:22
in Mathematics & Economics
LOS ANGELES (AP) -- A New Jersey pharmaceutical company has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud promoting two cancer drugs for unapproved purposes....